Evolus (EOLS) Non Operating Income (2017 - 2026)
Evolus (EOLS) reported Non Operating Income of $120000.0 for Q1 2026, up 110.53% on a YoY basis from $57000.0 in Q1 2025, and up 1100.0% quarter-over-quarter from $10000.0 in Q4 2025.
Evolus (EOLS) Non Operating Income (2017 - 2026) Analysis & Trends
Evolus has reported Non Operating Income for 9 years, with the latest figure at $120000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 110.53% year-over-year to $120000.0; the trailing twelve-month figure through Mar 2026 stood at -$476000.0 (down 442.45% YoY), and the FY2025 full-year result was -$539000.0, down 524.41% from the prior year.
- Non Operating Income for Q1 2026 stood at $120000.0, up from $10000.0 in the prior quarter.
- The five-year high for Non Operating Income was $694000.0 in Q4 2023, with the low at -$455000.0 in Q3 2025.
- Historically, Non Operating Income has averaged $23235.3 across 5 years, with a median of $19000.0 in 2023.
- Annual changes were most pronounced in 2023 — Non Operating Income sank 442.86% — and 2024, when it soared 1200.0%.
- Evolus' Non Operating Income stood at $84000.0 in 2022, then surged by 726.19% to $694000.0 in 2023, then plunged by 136.46% to -$253000.0 in 2024, then surged by 103.95% to $10000.0 in 2025, then soared by 1100.0% to $120000.0 in 2026.
- The last three Non Operating Income figures came in at $120000.0 (Q1 2026), $10000.0 (Q4 2025), and -$455000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | -253,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 694,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | -62,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2020 | -2.82 Mn |
| Sep 30, 2020 | -2.76 Mn |
| Jun 30, 2020 | -2.46 Mn |